z-logo
open-access-imgOpen Access
Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs
Author(s) -
Wu Jun,
Zhou Xing,
Tan Yuanqing,
Wang Liu,
Li Tianda,
Li Zhongwen,
Gao Tingting,
Fan Jiaqi,
Guo Baojie,
Li Wei,
Hao Jie,
Wang Xianguang,
Hu Baoyang
Publication year - 2020
Publication title -
cell proliferation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.647
H-Index - 74
eISSN - 1365-2184
pISSN - 0960-7722
DOI - 10.1111/cpr.12944
Subject(s) - covid-19 , pulmonary fibrosis , medicine , fibrosis , intensive care medicine , virology , disease , outbreak , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here